Whalley, et al (2011)
The SELECT trial for semaglutide showed a 20% reduction in major cardiovascular events over a mean 3.3 years in people with obesity and established cardiovascular disease
York B, Reineke EL, Sagen JV, Nikolai BC, Zhou S, Louet JF, Chopra AR, Chen X, Reed G, Noebels J, Adesina AM, Yu H, Wong LJ, Tsimelzon A, Hilsenbeck S, Stevens RD, Wenner BR, Ilkayeva O, Xu J, Newgard CB, OMalley BW
Work closely with your provider and stick with a dose until your body has completely adjusted
Convenient Home Delivery: For patient convenience, GLP-1 medications are safely packaged and shipped directly to your home
Consult your healthcare provider before use if you are pregnant, nursing, have a medical condition, or are taking medications